British households could be around £5,000 a year better off if the country did more to turn its scientific strengths into commercial success, former prime minister Gordon Brown has argued. Writing ahead of the Innovation Nation Conference in Manchester, Brown said the next decade is likely to bring the greatest scientific breakthroughs in a century — and that Britain's ability to benefit from them depends on whether innovation becomes a central goal of government policy.
Brown pointed to advances now under way in artificial intelligence, quantum computing and biology, and asked whether they can be used to tackle cancer, find ways to treat or prevent dementia, and overcome growing resistance to antibiotics. He also raised the question of whether science can deliver sustainable energy while protecting the environment, and whether AI can transform education, health and social care for millions of people while strengthening modern manufacturing.
At the centre of his argument is a gap between Britain's research base and its record at building global companies. The UK, he wrote, has a deep reservoir of assets but struggles to turn small companies into global success stories. The conference, which is expected to be addressed by the prime minister and by Andy Burnham, will hear that while the United States and China are the world's obvious innovation powerhouses, the UK also holds substantial advantages.
Brown cited Britain's university sector as a key part of that base. The country is home to four of the world's top 10 universities and 16 of the top 100, including five that rank among Europe's top 10 for spin-outs — startups built on intellectual property produced through university research. With less than 1% of the world's population, the UK produces 6% of the world's research papers, nearly 9% of citations and 12% of the most highly cited research.
Those figures underline the scale of the opportunity Brown describes, but also the scale of the problem. A strong record in producing research and citations has not translated into the kind of industrial and commercial returns that would lift household incomes. The £5,000 figure is presented as the potential gain from closing that gap — a measure of what Brown sees as the cost of failing to convert scientific talent into businesses, jobs and productivity.
The argument places science policy squarely inside the wider debate over Britain's economic future. Brown's intervention comes as the government faces pressure to show that research spending and industrial strategy can deliver visible benefits for ordinary households, not only for universities and technology firms. The conference in Manchester is intended to bring together inventors, investors and industrialists to discuss how the country can develop transformative technologies.
Brown's list of priorities — AI, quantum computing and biology — reflects where much of the current scientific momentum is concentrated. Each field carries the promise of major advances in medicine, energy and public services, but each also depends on long-term investment, skills and a regulatory environment that allows new products and companies to scale. The question Brown poses is whether Britain can organise itself to capture those gains rather than watching them develop elsewhere.
His answer is that innovation must sit at the heart of government policy. That means treating scientific research not as a distant or optional activity but as a driver of economic growth and public wellbeing. The coming decade, he suggests, will be defined by whether countries can turn breakthroughs into practical solutions for cancer, dementia, antibiotic resistance, energy and environmental protection — and whether Britain's inventors, investors and industrialists play a leading role in that work.